相似文献
1
Genetic mutations as risk predictors of atrial fibrillation recurrence after catheter ablation?基因突变作为导管消融术后房颤复发的风险预测指标？
J Am Coll Cardiol. 2010 Feb 23;55(8):754-7. doi: 10.1016/j.jacc.2009.12.009.
2
Genetic ACE I/D polymorphism and recurrence of atrial fibrillation after catheter ablation.血管紧张素转换酶基因 I/D 多态性与导管消融术后心房颤动复发。
Circ Arrhythm Electrophysiol. 2013 Aug;6(4):732-7. doi: 10.1161/CIRCEP.113.000253. Epub 2013 Jul 22.
3
Variations in the human soluble epoxide hydrolase gene and recurrence of atrial fibrillation after catheter ablation.人类可溶性环氧化物水解酶基因的变异与导管消融后心房颤动的复发。
Int J Cardiol. 2013 Oct 9;168(4):3647-51. doi: 10.1016/j.ijcard.2013.05.010. Epub 2013 May 25.
4
Rs4968309 in Myosin Light Chain 4 (MYL4) Associated With Atrial Fibrillation Onset and Predicts Clinical Outcomes After Catheter Ablation in Atrial Fibrillation Patients Without Structural Heart Disease.MYL4 基因中的 rs4968309 与无结构性心脏病的房颤患者导管消融术后房颤发作及临床结局相关
Circ J. 2019 Sep 25;83(10):1994-2001. doi: 10.1253/circj.CJ-19-0415. Epub 2019 Aug 10.
5
Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation.染色体 4q25 变异与导管消融术后心房颤动复发。
J Am Coll Cardiol. 2010 Feb 23;55(8):747-53. doi: 10.1016/j.jacc.2009.11.041.
6
Korean Atrial Fibrillation (AF) Network: Genetic Variants for AF Do Not Predict Ablation Success.韩国心房颤动（AF）网络：AF的基因变异不能预测消融成功率。
J Am Heart Assoc. 2015 Aug 13;4(8):e002046. doi: 10.1161/JAHA.115.002046.
7
Impact of left atrial geometric remodeling on late atrial fibrillation recurrence after catheter ablation.左心房几何重塑对导管消融术后晚期房颤复发的影响。
J Cardiovasc Med (Hagerstown). 2021 Dec 1;22(11):909-916. doi: 10.2459/JCM.0000000000001255.
8
Effectiveness of P-wave ECG index and left atrial appendage volume in predicting atrial fibrillation recurrence after first radiofrequency catheter ablation.P 波心电图指数和左心耳容积预测首次射频导管消融后心房颤动复发的效果。
BMC Cardiovasc Disord. 2021 Apr 6;21(1):164. doi: 10.1186/s12872-021-01930-w.
9
Safety, long-term outcomes and predictors of recurrence following a single catheter ablation procedure for atrial fibrillation.房颤单次导管消融术后的安全性、长期预后及复发预测因素
Acta Cardiol. 2019 Aug;74(4):319-324. doi: 10.1080/00015385.2018.1494114. Epub 2018 Oct 10.
10
Chromosome 4q25 variants and biomarkers of myocardial fibrosis in patients with atrial fibrillation.染色体 4q25 变异与心房颤动患者心肌纤维化的生物标志物。
J Cardiovasc Electrophysiol. 2019 Oct;30(10):1904-1913. doi: 10.1111/jce.14104. Epub 2019 Aug 26.
引用本文的文献
1
eNOS3 Genetic Polymorphism Is Related to Post-Ablation Early Recurrence of Atrial Fibrillation.内皮型一氧化氮合酶3基因多态性与房颤消融术后早期复发有关。
Yonsei Med J. 2015 Sep;56(5):1244-50. doi: 10.3349/ymj.2015.56.5.1244.
2
Genome-wide association studies of atrial fibrillation: past, present, and future.全基因组关联研究心房颤动：过去、现在和未来。
Cardiovasc Res. 2011 Mar 1;89(4):701-9. doi: 10.1093/cvr/cvr001. Epub 2011 Jan 18.
本文引用的文献
1
Effect of Angiotensin converting enzyme inhibitors and Angiotensin receptor blockers on patients following ablation of atrial fibrillation.血管紧张素转化酶抑制剂和血管紧张素受体阻滞剂对房颤消融术后患者的影响。
Korean Circ J. 2009 May;39(5):185-9. doi: 10.4070/kcj.2009.39.5.185. Epub 2009 May 28.
2
Predicting successful pulmonary vein isolation in patients with atrial fibrillation by brain natriuretic Peptide plasma levels.通过血浆脑钠肽水平预测心房颤动患者肺静脉隔离术的成功率
Indian Pacing Electrophysiol J. 2009 Sep 1;9(5):241-6.
3
Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry.在欧洲血统个体中，ZFHX3基因的变异与心房颤动有关。
Nat Genet. 2009 Aug;41(8):879-81. doi: 10.1038/ng.416. Epub 2009 Jul 13.
4
A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke.位于16号染色体长臂22区的ZFHX3基因中的一个序列变异与房颤和缺血性中风相关。
Nat Genet. 2009 Aug;41(8):876-8. doi: 10.1038/ng.417. Epub 2009 Jul 13.
5
Systematic review: comparative effectiveness of radiofrequency catheter ablation for atrial fibrillation.系统评价：射频导管消融治疗心房颤动的比较疗效
Ann Intern Med. 2009 Aug 4;151(3):191-202. doi: 10.7326/0003-4819-151-3-200908040-00131. Epub 2009 Jul 6.
6
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association.心血管风险新标志物评估标准：美国心脏协会的科学声明
Circulation. 2009 May 5;119(17):2408-16. doi: 10.1161/CIRCULATIONAHA.109.192278. Epub 2009 Apr 13.
7
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study.心房颤动风险评分的开发（弗雷明汉心脏研究）：一项基于社区的队列研究。
Lancet. 2009 Feb 28;373(9665):739-45. doi: 10.1016/S0140-6736(09)60443-8.
8
Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation.与心房颤动相关的4号染色体q25区域变异的大规模复制及荟萃分析。
Eur Heart J. 2009 Apr;30(7):813-9. doi: 10.1093/eurheartj/ehn578. Epub 2009 Jan 13.
9
Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study.导管消融与抗心律失常药物治疗心房颤动：A4研究
Circulation. 2008 Dec 9;118(24):2498-505. doi: 10.1161/CIRCULATIONAHA.108.772582. Epub 2008 Nov 24.
10
Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation.肺静脉隔离术后房颤复发的消融前预测因素：炎症的潜在作用。
Europace. 2009 Feb;11(2):158-63. doi: 10.1093/europace/eun309. Epub 2008 Nov 13.
Zotero 插件